<DOC>
	<DOCNO>NCT02120833</DOCNO>
	<brief_summary>This study infants mild moderate dry itchy skin . This study involve go doctor 6 visit 2 week . All participant ' skin examine dermatologist determine atopic dermatitis active mild moderate eczema wound . Participant 's parents/guardians ask question determine child qualifies study . Then participant ' caregiver complete questionnaire beginning study . The child 's skin examine rate level eczema train examiner grade look symptom eczema . All parent guardian instruct apply test product record usage diary card apply test product . The test product apply least 2 time per day need body area , include face affect throughout study . One digital picture take one eczema wound . Another digital picture take area around wound . These picture take Day 0 ( Baseline ) , Day 3 , Day 14 . Once product applied skin examine adverse event participant ' caregiver complete questionnaire study day 1 , 3 , 7 14 .</brief_summary>
	<brief_title>A Test Determine Usefulness Safety Cream Used Babies With Dry Itchy Skin</brief_title>
	<detailed_description>This multi-center , two-arm clinical trial participant age 2 - 35 month mild moderate Atopic Dermatitis ( AD ) determine study physician . A sufficient number participant enrol study yield 40 participant complete trial , 30 investigational product group 10 active control group . The investigational control ( EpiCeramÂ® ) product use topically . Participant caregiver instruct gently massage assign product participant 's skin . The treatment apply least 2 time per day body area , include area body face affect AD . No product apply within 4 hour site visit . These treatment use place participant 's current moisturizers and/or emollient . Diaries complete participant ' caregiver day , begin upon initiation therapy continue trial completion/discontinuation , include information product application use rescue medication . All participant visit clinical site assessment baseline ( Day 0 ) Days 1 , 2 , 3 , 7 14 . Clinical assessment include Eczema Area Severity index ( EASI ) Investigator 's Global Atopic Dermatitis Assessment ( IGADA ) . Instrumental assessment hydration do use Corneometer ( Courage &amp; Khazaka , Germany ) . Caregivers also complete questionnaire assess product experience . The final visit occur Day 14 day participant withdrawal trial .</detailed_description>
	<criteria>Inclusion Criteria 1 . Able comprehend follow requirement study ( include availability schedule visit date ) base upon research site personnel 's assessment ; 2 . Caregiver able willing provide write informed consent participant participate trial ; 3 . Male female race ethnicity , 2 month 35 month age ; 4 . Diagnosed Atopic Dermatitis ( AD ) basis criterion define Hanifin Rajka 5 . Rated mild moderate AD ( grade 3.0 7.5 inclusive ) per RajkaLangeland severity index 6 . Willing stop emollient , moisturizers and/or skin barrier cream emulsion treatment AD condition test period . If use corticosteroid ( Class I , II , III ) immunomodulators study entry , must stable dose minimum 1 month ; 7 . Willing undergo washout period 2 day trial initiation use moisturizers emollient allow ; 8 . Willing able comply schedule visit , treatment plan , trial procedure . 1 . Known sensitivity investigational product ingredient ; 2 . Use therapeutic ( counter prescription ) body wash contains active ingredient eczema ; 3 . Participation clinical study within 30 day Visit 1 ; 4 . Relative , partner staff clinical research site personnel ; 5 . Active infection type start study ; 6 . Severe AD determine RajkaLangeland Severity Index 7 . AD require systemic , superpotent ( Class I ) potent ( Class II III ) topical corticosteroid . If participant require medication rescue therapy study , participant discontinue trial ; 8 . Requires inhale intranasal corticosteroid ; 9 . Other medical condition may increase risk associate study participation investigational product administration may interfere interpretation study result , judgment investigator , would make participant inappropriate entry study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>